BUY Adriconomics Convinzione4/5 Qualità dell'analisi75/100 ora
Adriconomics is buying SMTI, a micro-cap healthcare company focused on wound care, because his custom 'value ratio' indicator shows it is incredibly cheap, similar to Google. He highlights strong revenue growth (34% last year) and high gross margins (85-90%), expecting valuation to expand as the company approaches profitability. Despite risks like debt and share dilution, he notes the CEO's significant ownership and a new product launch as mitigators.
“I just bought 750 shares for over $20,000. It's a completely unknown ticker you probably never heard. It's a micro cap with a multi-bagger potential that it's currently trading at half its fair value.” — ▶ Guarda clip